标题
Novel therapeutic approaches for treatment of COVID-19
作者
关键词
-
出版物
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 98, Issue 6, Pages 789-803
出版商
Springer Science and Business Media LLC
发表日期
2020-06-04
DOI
10.1007/s00109-020-01927-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coronavirus infections and immune responses
- (2020) Geng Li et al. JOURNAL OF MEDICAL VIROLOGY
- Potential interventions for novel coronavirus in China: A systematic review
- (2020) Lei Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Reducing mortality from 2019-nCoV: host-directed therapies should be an option
- (2020) Alimuddin Zumla et al. LANCET
- COVID-19: what is next for public health?
- (2020) David L Heymann et al. LANCET
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China
- (2020) Fei Yu et al. MICROBES AND INFECTION
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- Remdesivir as a possible therapeutic option for the COVID-19
- (2020) Jaffar A. Al-Tawfiq et al. Travel Medicine and Infectious Disease
- Covid-19: a puzzle with many missing pieces
- (2020) Pauline Vetter et al. BMJ-British Medical Journal
- Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting
- (2020) Barry J. Liang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
- (2020) Balamurugan Shanmugaraj et al. Pathogens
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients
- (2020) Meijuan Zheng et al. Cellular & Molecular Immunology
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
- (2020) Zeming Liu et al. JOURNAL OF INFECTION
- Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
- (2020) Fan Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
- (2020) Hao Cheng et al. JOURNAL OF MEDICAL VIROLOGY
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus
- (2020) Deepak Jakhar et al. NATURE MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how?
- (2020) Pierre Tiberghien et al. VOX SANGUINIS
- Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
- (2020) Wen-Hsiang Chen et al. Human Vaccines & Immunotherapeutics
- Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use
- (2020) Elia Bari et al. Cells
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
- (2020) Andrea Cortegiani et al. JOURNAL OF CRITICAL CARE
- Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome
- (2020) Daniela Weiskopf et al. Science Immunology
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
- (2019) Laura M. McLane et al. Annual Review of Immunology
- Cigarette smoke exposure reduces leukemia inhibitory factor levels during respiratory syncytial viral infection
- (2019) Justin Poon et al. International Journal of Chronic Obstructive Pulmonary Disease
- An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals
- (2019) Michael C. Sneller et al. Science Translational Medicine
- Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
- (2018) Leen Delang et al. ANTIVIRAL RESEARCH
- BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity
- (2018) Rob J.W. Arts et al. Cell Host & Microbe
- Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study
- (2018) John H Beigel et al. LANCET INFECTIOUS DISEASES
- Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial
- (2018) Yaseen M. Arabi et al. Trials
- Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model
- (2018) Mahesh Khatri et al. Stem Cell Research & Therapy
- Study of the immunomodulatory effects of osteogenic differentiated human dental pulp stem cells
- (2018) Nikoo Hossein-khannazer et al. LIFE SCIENCES
- Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity
- (2018) Anna C.C. Aguiar et al. International Journal for Parasitology-Drugs and Drug Resistance
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Human monoclonal antibodies as candidate therapeutics against emerging viruses
- (2017) Yujia Jin et al. Frontiers of Medicine
- Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide
- (2016) Sharline Madera et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus–Derived CD8+T Cell Epitopes and Host MHC
- (2016) William J. Liu et al. JOURNAL OF IMMUNOLOGY
- Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo
- (2016) Thomas Luke et al. Science Translational Medicine
- Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
- (2016) Oi-Wing Ng et al. VACCINE
- 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
- (2016) Reed F. Johnson et al. VIROLOGY
- Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice
- (2016) Yan Li et al. Stem Cell Research & Therapy
- Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome
- (2016) Davide Corti et al. Journal of Infection and Public Health
- Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma
- (2015) Xiao-Xin Wu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques
- (2015) L Liu et al. Mucosal Immunology
- Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors
- (2015) Encouse B. Golden et al. Neurosurgical Focus
- Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
- (2015) Davide Corti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
- (2015) Yaseen Arabi et al. SpringerPlus
- Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
- (2014) Sheng-Fan Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection
- (2014) Robert F Foronjy et al. BMC IMMUNOLOGY
- Understanding the T cell immune response in SARS coronavirus infection
- (2012) Hsueh-Ling Janice Oh et al. Emerging Microbes & Infections
- Interferon and cytokine responses to SARS-coronavirus infection
- (2008) Volker Thiel et al. CYTOKINE & GROWTH FACTOR REVIEWS
- SARS coronavirus and innate immunity
- (2007) Matthew Frieman et al. VIRUS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now